Acid-mediated tumor invasion: a multidisciplinary study.

The acid-mediated tumor invasion hypothesis proposes altered glucose metabolism and increased glucose uptake, observed in the vast majority of clinical cancers by fluorodeoxyglucose-positron emission tomography, are critical for development of the invasive phenotype. In this model, increased acid production due to altered glucose metabolism serves as a key intermediate by producing H(+) flow along concentration gradients into adjacent normal tissue. This chronic exposure of peritumoral normal tissue to an acidic microenvironment produces toxicity by: (a) normal cell death caused by the collapse of the transmembrane H(+) gradient inducing necrosis or apoptosis and (b) extracellular matrix degradation through the release of cathepsin B and other proteolytic enzymes. Tumor cells evolve resistance to acid-induced toxicity during carcinogenesis, allowing them to survive and proliferate in low pH microenvironments. This permits them to invade the damaged adjacent normal tissue despite the acid gradients. Here, we describe theoretical and empirical evidence for acid-mediated invasion. In silico simulations using mathematical models provide testable predictions concerning the morphology and cellular and extracellular dynamics at the tumor-host interface. In vivo experiments confirm the presence of peritumoral acid gradients as well as cellular toxicity and extracellular matrix degradation in the normal tissue exposed to the acidic microenvironment. The acid-mediated tumor invasion model provides a simple mechanism linking altered glucose metabolism with the ability of tumor cells to form invasive cancers.

[1]  Otto Warburn,et al.  THE METABOLISM OF TUMORS , 1931 .

[2]  M Hatanaka,et al.  Transport of sugars in tumor cell membranes. , 1974, Biochimica et biophysica acta.

[3]  J. Gross,et al.  A transparent access chamber for the rat dorsal skin fold. , 1979, Microvascular research.

[4]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[5]  R K Jain,et al.  Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. , 1994, Cancer research.

[6]  Bonnie F. Sloane,et al.  Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. , 1994, Cancer research.

[7]  R. Gillies,et al.  31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. , 1994, The American journal of physiology.

[8]  S. Dairkee,et al.  Selective cell culture of primary breast carcinoma. , 1995, Cancer research.

[9]  R. Gatenby,et al.  The potential role of transformation-induced metabolic changes in tumor-host interaction. , 1995, Cancer research.

[10]  E. T. Gawlinski,et al.  A reaction-diffusion model of cancer invasion. , 1996, Cancer research.

[11]  M. Dewhirst,et al.  Microvascular studies on the origins of perfusion-limited hypoxia. , 1996, The British journal of cancer. Supplement.

[12]  David E. Housman,et al.  Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.

[13]  M. Dewhirst,et al.  Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. , 1996, Cancer research.

[14]  Rakesh K. Jain,et al.  Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.

[15]  T. Ohtsubo,et al.  Acidic environment causes apoptosis by increasing caspase activity , 1999, British Journal of Cancer.

[16]  M. Neeman,et al.  Dynamic remodeling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice. , 1999, Neoplasia.

[17]  C. Paraskeva,et al.  An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis , 1999, Oncogene.

[18]  K. Kato,et al.  Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. , 2000, Cancer research.

[19]  J. Abbruzzese,et al.  Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells , 2001, Oncogene.

[20]  N. Nishiumi,et al.  18F-FDG PET detection of colonic adenomas. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  A. Lardner The effects of extracellular pH on immune function , 2001, Journal of leukocyte biology.

[22]  R K Jain,et al.  Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. , 2001, Cancer research.

[23]  S. Gambhir Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.

[24]  E. T. Gawlinski,et al.  The possible role of postoperative azotemia in enhanced survival of patients with metastatic renal cancer after cytoreductive nephrectomy. , 2002, Cancer research.

[25]  D Artemov,et al.  Combined vascular and extracellular pH imaging of solid tumors , 2002, NMR in biomedicine.

[26]  Huasheng Lu,et al.  Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis* , 2002, The Journal of Biological Chemistry.

[27]  M. Solaiyappan,et al.  Extracellular acidification alters lysosomal trafficking in human breast cancer cells. , 2003, Neoplasia.

[28]  Robert J Gillies,et al.  Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors. , 2003, Neoplasia.

[29]  E. T. Gawlinski,et al.  The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. , 2003, Cancer research.

[30]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[31]  T. Turkington,et al.  Clinical applications of PET in oncology. , 2004, Radiology.

[32]  C. Dooms,et al.  Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. , 2004, The Lancet. Oncology.

[33]  M. Leblanc,et al.  FDG-PET prediction of head and neck squamous cell cancer outcomes. , 2004, Archives of otolaryngology--head & neck surgery.

[34]  Craig K Abbey,et al.  In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Alavi,et al.  Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer. , 2005, Radiologic clinics of North America.